CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-27 | Adamczyk Darius Director | Grant or award · Deferred Share Units | +1,193.98 | 2,258.52 | ||
| 2023-03-07 | Washington A. Eugene Director | Grant or award · Deferred Share Units | +201.41 | $155.16 | $31K | 28,569.45 |
| 2023-03-07 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +233.63 | $155.16 | $36K | 6,430.93 |
| 2023-03-06 | Swanson James D. | Sale | −1,061.68 | $154.66 | $164K | 9,215.32 |
| 2023-02-13 | Wolk Joseph J Exec VP, CFO | Grant or award | +20,693 | 58,975.2 | ||
| 2023-02-13 | Wolk Joseph J Exec VP, CFO | Shares withheld for taxes | −8,578 | $162.01 | $1.4M | 50,397.2 |
| 2023-02-13 | Wolk Joseph J Exec VP, CFO | Grant or award · Employee Stock Options (Right to Buy) | +88,334 | 88,334 | ||
| 2023-02-13 | Wolk Joseph J Exec VP, CFO | Grant or award · Restricted Share Units | +5,338 | 5,338 | ||
| 2023-02-13 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award | +10,839 | 83,289.87 | ||
| 2023-02-13 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Shares withheld for taxes | −4,891 | $162.01 | $792K | 78,398.87 |
| 2023-02-13 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award · Employee Stock Options (Right to Buy) | +32,317 | 32,317 | ||
| 2023-02-13 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award · Restricted Share Units | +1,953 | 1,953 | ||
| 2023-02-13 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Grant or award | +21,422 | 150,159 | ||
| 2023-02-13 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Shares withheld for taxes | −10,569 | $162.01 | $1.7M | 139,590 |
| 2023-02-13 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Grant or award · Employee Stock Options (Right to Buy) | +64,634 | 64,634 | ||
| 2023-02-13 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Grant or award · Restricted Share Units | +3,906 | 3,906 | ||
| 2023-02-13 | Swanson James D. | Grant or award | +3,228 | 11,195 | ||
| 2023-02-13 | Swanson James D. | Shares withheld for taxes | −918 | $162.01 | $149K | 10,277 |
| 2023-02-13 | Swanson James D. | Grant or award · Employee Stock Options (Right to Buy) | +22,191 | 22,191 | ||
| 2023-02-13 | Swanson James D. | Grant or award · Restricted Share Units | +1,341 | 1,341 |
Page 35 of 60 · 1,189 trades